Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hesketh

Showing results (151-160 of 248) with videos related to

Pageof 25
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 21, 2023
2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following high-emetic-risk antineoplastic agentsJørn Herrstedt, L Celio, P J Hesketh, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 15, 2016
Erratum to: 2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapyFausto Roila, David Warr, Paul J Hesketh, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 26, 2010
Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity--state of the artSteven M Grunberg, David Warr, Richard J Gralla, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 23, 2016
2016 Updated MASCC/ESMO Consensus Recommendations: Prevention of Nausea and Vomiting Following High Emetic Risk ChemotherapyJørn Herrstedt, Fausto Roila, David Warr, et al.
The Cancer Journal From Scientific American|May 1, 1997
Improved control of high-dose-cisplatin-induced acute emesis with the addition of prochlorperazine to granisetron/dexamethasoneP J Hesketh, D R Gandara, A M Hesketh, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 20, 2023
2023 updated MASCC/ESMO Consensus recommendations: Prevention of nausea and vomiting following moderately emetic risk antineoplastic agentsFlorian Scotté, Lee Schwartzberg, Hirotoshi Iihara, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 12, 2016
2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapyFausto Roila, David Warr, Paul J Hesketh, et al.
Biochemical Society Transactions|November 1, 1993
The temporal expression of cellular oncogenes in mechanically stimulated muscleN J Osbaldeston, D M Lee, V M Cox, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 21, 2023
Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents-updated MASCC/ESMO consensus recommendationKarin Jordan, Alexandre Chan, Richard J Gralla, et al.
Cancer|May 14, 2016
Efficacy of the neurokinin-1 receptor antagonist rolapitant in preventing nausea and vomiting in patients receiving carboplatin-based chemotherapyPaul J Hesketh, Ian D Schnadig, Lee S Schwartzberg, et al.
Pageof 25

Showing results (151-160 of 248) with videos related to

Sort By:
Pageof 25
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 21, 2023
2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following high-emetic-risk antineoplastic agentsJørn Herrstedt, L Celio, P J Hesketh, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 15, 2016
Erratum to: 2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapyFausto Roila, David Warr, Paul J Hesketh, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 26, 2010
Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity--state of the artSteven M Grunberg, David Warr, Richard J Gralla, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 23, 2016
2016 Updated MASCC/ESMO Consensus Recommendations: Prevention of Nausea and Vomiting Following High Emetic Risk ChemotherapyJørn Herrstedt, Fausto Roila, David Warr, et al.
The Cancer Journal From Scientific American|May 1, 1997
Improved control of high-dose-cisplatin-induced acute emesis with the addition of prochlorperazine to granisetron/dexamethasoneP J Hesketh, D R Gandara, A M Hesketh, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 20, 2023
2023 updated MASCC/ESMO Consensus recommendations: Prevention of nausea and vomiting following moderately emetic risk antineoplastic agentsFlorian Scotté, Lee Schwartzberg, Hirotoshi Iihara, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 12, 2016
2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapyFausto Roila, David Warr, Paul J Hesketh, et al.
Biochemical Society Transactions|November 1, 1993
The temporal expression of cellular oncogenes in mechanically stimulated muscleN J Osbaldeston, D M Lee, V M Cox, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 21, 2023
Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents-updated MASCC/ESMO consensus recommendationKarin Jordan, Alexandre Chan, Richard J Gralla, et al.
Cancer|May 14, 2016
Efficacy of the neurokinin-1 receptor antagonist rolapitant in preventing nausea and vomiting in patients receiving carboplatin-based chemotherapyPaul J Hesketh, Ian D Schnadig, Lee S Schwartzberg, et al.
Pageof 25